Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Monday, April 30, 2018
DOJ Takes Rare Step Intervening in Qui Tam to Add PE Firm and Individuals
On Feb. 16, the U.S. Department of Justice (DOJ) filed a complaint intervening in a qui tam action that two former employees brought against their former employer, Patient Care America (PCA), a compounding pharmacy located in Pompano Beach, Florida, complaint filed by the U.S. Department of Justice, United States Medrano v. Diabetic Care Rx, No. 15-cv-62617 (S.D.FL.). In its complaint, the DOJ alleges unjust enrichment, payment by mistake, and violations of the False Claims Act, 31 U.S.C. Sections 3729-33.
By Vasilios J. Kalogredis|April 30, 2018 at 02:47 PM